Artificial Intelligence-Assisted Design of Nanomedicines for Breast Cancer Diagnosis and Therapy: Advances, Challenges, and Future Directions
Проектирование нанопрепаратов с использованием искусственного интеллекта для диагностики и терапии рака молочной железы: достижения, проблемы и перспективные направления
2025-05-21
SCID: 54.1/wxyfnrgq
Discuss with AI
AI-assisted nanomedicinebreast cancer diagnosisdeep learning modelstargeted drug deliverytheranostic nanoparticles
Figures from the paper
Abstract (AI)
This paper explores the revolutionary collaboration between artificial intelligence (AI) and nanotechnology in detecting and treating breast cancer. It highlights the synergistic potential of both fields to overcome significant limitations of modern approaches. Clinical applications and research demonstrate the diversity and depth of AI-based deep learning models in diagnostics, improving diagnostic accuracy and enabling precise, individualized therapy through advanced imaging and biomarker discovery. Through intelligent nanocarriers, nanotechnology contributes to these advancements by enabling targeted drug delivery, minimizing systemic toxicity, and providing theranostic capabilities for real-time monitoring. However, challenges remain, including data accessibility, model interpretability, scalability in nanocarrier manufacturing, and tumor diversity. Future improvements should focus on developing multifunctional nanoparticles, flexible AI algorithms, and scalable, cost-effective solutions to enhance accessibility and clinical integration. Hence, the study emphasizes the need for multidisciplinary collaboration to eliminate existing barriers and generate advancements to transform breast cancer therapies into more effective, safer, and individualized methods. Graphical Abstract
Key Findings
1
AI enables more precise and individualized breast cancer therapy by supporting patient-specific diagnostic and treatment decisions.
2
AI-based deep learning improves breast cancer diagnostic accuracy through advanced imaging analysis and biomarker discovery.
3
Future progress requires multifunctional nanoparticles, adaptable AI algorithms, scalable cost-effective solutions, and multidisciplinary collaboration for clinical integration.
4
Intelligent nanocarriers facilitate targeted drug delivery, reduce systemic toxicity, and provide theranostic capabilities for real-time monitoring.
5
Major barriers include limited data accessibility, poor model interpretability, difficulties scaling nanocarrier manufacturing, and tumor heterogeneity.
Research Object
AI-assisted nanomedicines for breast cancer diagnosis and therapy
Research Subject
Integration of AI-based diagnostic and therapeutic capabilities with intelligent nanocarriers to improve diagnostic accuracy, enable individualized targeted treatment and real-time theranostic monitoring while reducing systemic toxicity
Publication Details
Publication Date
2025-05-21
Journal
Publisher
ISSN
Cited by
118
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest